Balaxi Pharmaceuticals Ltd (BALAXI) Stock Price & News

BALAXI:NSE

Balaxi Pharmaceuticals Ltd

₹23.50

-1.43%

(-0.34) 1D

Nov 13, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 12, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (INR)

805.44M / -

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	725.42M	707.14M	806.82M	-
Cost of goods sold	417.35M	414.90M	431.74M	-
Cost of revenue	417.35M	414.90M	431.74M	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	277.18M	291.02M	328.46M	-
Operating expense	282.77M	297.48M	336.94M	-
Total operating expenses	700.12M	712.38M	768.68M	-
Operating income	25.30M	-5.25M	38.14M	28.71M
Other non operating income	957.00K	18.30M	-9.92M	-
EBT including unusual items	16.10M	14.03M	20.89M	20.15M
EBT excluding unusual items	16.10M	12.99M	20.89M	-
Income tax expense	13.05M	7.90M	7.92M	8.65M
Effective tax rate	81.05%	56.31%	37.90%	42.93%
Other operating expenses	-	-	-	-
Net income	3.05M	6.13M	12.97M	-
Net profit margin	0.42%	0.87%	1.61%	1.43%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-10.16M	-9.90M	-7.33M	-8.56M
Net interest expenses	-10.16M	-9.90M	-7.33M	-
Depreciation and amortization charges	5.60M	6.46M	8.48M	-
EBITDA	29.57M	-328.75K	43.06M	40.06M
Gain or loss from assets sale	-	-	-	-

Finance